Difference between revisions of "Team:BIT/nb"

 
(19 intermediate revisions by 4 users not shown)
Line 52: Line 52:
 
<div class="col-xs-10 text-right menu-1">
 
<div class="col-xs-10 text-right menu-1">
 
<ul>
 
<ul>
<li class="active"><a href="目录.html">Home</a></li>
+
<li><a href="../portfolio.html">Practice</a></li>
+
 +
<li class="has-dropdown">
 +
<a>Project</a>
 +
<ul class="dropdown">
 +
<li><a href="https://2017.igem.org/Team:BIT/Design">Design</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/Demonstrate">Demonstrate</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/Model">Model</a></li>
 +
</ul>
 +
</li>
 
<li class="has-dropdown">
 
<li class="has-dropdown">
<a href="../blog.html">Blo</a>
+
<a href="https://2017.igem.org/Team:BIT/achievement">Achievement</a>
 
<ul class="dropdown">
 
<ul class="dropdown">
<li><a href="#">Design</a></li>
+
<li><a href="https://2017.igem.org/Team:BIT/Medal">Medal</a></li>
<li><a href="#">Demonstrate</a></li>
+
<li><a href="https://2017.igem.org/Team:BIT/Prize">Prize</a></li>
<li><a href="#">Model</a></li>
+
<li><a href="https://2017.igem.org/Team:BIT/Parts">Part</a></li>
 +
                                                                        <li><a href="https://2017.igem.org/Team:BIT/Safety">Safety Form</a></li>
 
</ul>
 
</ul>
 
</li>
 
</li>
<li><a href="../about.html">Achievement</a></li>
+
                       
<li><a href="../contact.html">Notebook</a></li>
+
<li class="has-dropdown">
<li class="btn-cta"><a href="#"><span>Team</span></a></li>
+
<a href="https://2017.igem.org/Team:BIT/HP">Practice</a>
 +
<ul class="dropdown">
 +
<li><a href="https://2017.igem.org/Team:BIT/HP/Silver">Silver</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/HP/Gold_Integrated">Gold</a></li>
 +
        <li><a href="https://2017.igem.org/Team:BIT/Engagement"> Engagement</a></li>
 +
                                                                <li><a href="https://2017.igem.org/Team:BIT/Entrepreneurship">Entreperneurship</a></li>
 +
</ul>
 +
</li>
 +
<li class="has-dropdown">
 +
<a href="https://2017.igem.org/Team:BIT/Notebook"style="color:#1b8fac">Notebook</a>
 +
<ul class="dropdown">
 +
<li><a href="https://2017.igem.org/Team:BIT/Gallery">Gallery</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/Track">Track</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/nb">Journal</a></li>
 +
                                                                <li><a href="https://2017.igem.org/Team:BIT/Protocol">Protocol</a></li>
 +
</ul>
 +
</li>
 +
                                                        <li class="has-dropdown">
 +
<a href="https://2017.igem.org/Team:BIT/Team">Team</a>
 +
<ul class="dropdown">
 +
<li><a href="https://2017.igem.org/Team:BIT/Collaborations">Collaborations</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/Team/Member">Member</a></li>
 +
<li><a href="https://2017.igem.org/Team:BIT/Attributions">Attributions</a></li>
 +
</ul>
 +
</li>
 +
<li class="btn-cta"><a href="https://2017.igem.org/Team:BIT"><span>Home</span></a></li>
 
</ul>
 
</ul>
 
</div>
 
</div>
Line 72: Line 106:
 
</div>
 
</div>
 
</nav>
 
</nav>
 +
 
   
 
   
  
Line 80: Line 115:
 
     <p>&nbsp;</p>
 
     <p>&nbsp;</p>
 
<p><span class="label-warning"><font size=4><font color=black> March: </font> </font></span></p>
 
<p><span class="label-warning"><font size=4><font color=black> March: </font> </font></span></p>
   </span><p>&nbsp;&nbsp;
+
   </span><p>&nbsp;&nbsp;<br>
 
+
i. Week 1-2 (2017.03.04-2017.03.17)
i. Week1-2 2017.03.04-2017.03.17:
+
 
   <br>
 
   <br>
   &nbsp;&nbsp;After discussion, the main goal of our project was to detect cancer of the liver by using small molecule
+
   &nbsp;&nbsp;&nbsp;
 +
After discussion, the main goal of our project was to detect cancer of the liver by using small molecule
  
&nbsp;&nbsp;<br>
 
ii. Week3 2017.03.18-2017.03.24:</span><br>
 
  &nbsp;&nbsp;After reviewing the literature, we chose lysine as our small molecule and chose lysine-deficient
 
 
<br>
 
<br>
 
+
ii. Week 3 (2017.03.18-2017.03.24)
&nbsp;&nbsp;
+
iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  &nbsp;&nbsp;
+
iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Industrial chain is currently complete
+
After reviewing the literature, we chose lysine as our small molecule and chose lysine-deficient E.coli as our bacteria.
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
 
  3. Technological applications are matured</p>
 
  
 +
iii. week 4 (2017.03.25-2017.03.31)</span><br>
 +
  &nbsp;&nbsp;&nbsp;
 +
We chose our main experimental method.<br>
 +
 
 +
</p>
  
  
    <p>&nbsp;</p>
+
 
 +
      <p>&nbsp;</p>
 
<p><span class="label-warning"><font size=4><font color=black> April: </font> </font></span></p>
 
<p><span class="label-warning"><font size=4><font color=black> April: </font> </font></span></p>
   <span class="lead">&nbsp;&nbsp;
+
   </span><p>&nbsp;&nbsp;<br>
<p>
+
i. Week 5 (2017.04.01-2017.04.07)
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Branding Barrier.
+
We listed the plasmids we might use, designed the gene lines, began to construct our part.
 +
 
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
ii. Week 6 2017.04.08-2017.04.14)
  3. Strict Market Admittance Criteria.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  4. Distribution Barrier.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Industrial chain is currently complete
+
We constructed our first part BBa_K2305008.
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
 
  3. Technological applications are matured</p>
 
  
    <p>&nbsp;</p>
+
iii. Week 7 (2017.04.15-2017.04.21)
<p><span class="label-warning"><font size=4><font color=black> May: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p> 
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
   2. Branding Barrier.
+
We constructed our part BBa_K2305011、BBa_K2305012 and BBa_K2305003、BBa_K2305002.<br>
 +
    
 +
iv.    Week 8 (2017.04.22-2017.04.28)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
  3. Strict Market Admittance Criteria.<br>
+
We import BBa_K876070 to E.coli, detect the growth and fluorescence curve of E.coil under various lysine concentration.<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
</p>
  4. Distribution Barrier.<br>
+
 
  <span class="lead">&nbsp;&nbsp;
+
 
  iii. Opportunity:</span><br>
+
      <p>&nbsp;</p>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
<p><span class="label-warning"><font size=4><font color=black>May: </font> </font></span></p>
  1. Favorable national economic condition.<br>
+
   </span><p>&nbsp;&nbsp;<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
i. Week 9 (2017.04.29-2017.05.05)
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
   iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Industrial chain is currently complete
+
We constructed BBa_K2305009、BBa_K2305010.
 +
 
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
ii. Week 10 (2017.05.06-2017.05.12)
  3. Technological applications are matured</p>
+
    <p>&nbsp;</p>
+
<p><span class="label-warning"><font size=4><font color=black> June: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p>  
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Branding Barrier.
+
We constructed BBa_K2305014、BBa_K2305015、BBa_K2305016.
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
 
  3. Strict Market Admittance Criteria.<br>
+
iii. Week 11 (2017.05.13-2017.05.19)
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  4. Distribution Barrier.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
   2. Industrial chain is currently complete
+
We constructed BBa_K2305007、BBa_K2305006.<br>
 +
    
 +
iv.    Week 12 (2017.05.20-2017.05.26)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
   &nbsp;&nbsp;&nbsp;
  3. Technological applications are matured</p>
+
We constructed BBa_K2305016、BBa_K2305005.<br>
    <p>&nbsp;</p>
+
v.     Week 13 (2017.05.27-2017.06.02)
<p><span class="label-warning"><font size=4><font color=black> July: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p> 
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
  2. Branding Barrier.
+
We constructed BBa_K2305004、BBa_K2305013.<br>
 +
</p>
 +
 +
 
 +
      <p>&nbsp;</p>
 +
<p><span class="label-warning"><font size=4><font color=black>June: </font> </font></span></p>
 +
  </span><p>&nbsp;&nbsp;<br>
 +
i. Week 14 (2017.06.03-2017.06.09)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  3. Strict Market Admittance Criteria.<br>
+
We begin to detect the growth and fluorescence curve of E.coil which imported our plasmids.
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
 
  4. Distribution Barrier.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
ii. Week 15-17 (2017.06.10-2017.06.30)
  2. Industrial chain is currently complete
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  3. Technological applications are matured</p>
+
We have achieved the detection of the growth and fluoresence curve of E.coli imported our plasmids.
    <p>&nbsp;</p>
+
<p><span class="label-warning"><font size=4><font color=black> August: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p> 
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
</p>
  2. Branding Barrier.
+
 
 +
 
 +
      <p>&nbsp;</p>
 +
<p><span class="label-warning"><font size=4><font color=black>July: </font> </font></span></p>
 +
  </span><p>&nbsp;&nbsp;<br>
 +
i. Week 18 (2017.07.01-2017.07.07)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  3. Strict Market Admittance Criteria.<br>
+
We tried to knock out the lysa gene in E.coli by λRed recombination system.  
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
 
  4. Distribution Barrier.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
ii. Week 19 ( 2017.07.08-2017.07.14)
  2. Industrial chain is currently complete
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  3. Technological applications are matured</p>
+
We discussed about the problems we met in the gene-knocked.
    <p>&nbsp;</p>
+
<p><span class="label-warning"><font size=4><font color=black> September: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p> 
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
 
  2. Branding Barrier.
+
iii. Week 20-21 (2017.07.15-2017.07.28)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
  3. Strict Market Admittance Criteria.<br>
+
We learned how to produce competent cells and produced enough cells..<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
</p>
  4. Distribution Barrier.<br>
+
 
  <span class="lead">&nbsp;&nbsp;
+
      <p>&nbsp;</p>
  iii. Opportunity:</span><br>
+
<p><span class="label-warning"><font size=4><font color=black>August: </font> </font></span></p>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   </span><p>&nbsp;&nbsp;<br>
  1. Favorable national economic condition.<br>
+
i. Week 22-23 (2017.07.29-2017.08.16)
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
   iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Industrial chain is currently complete
+
We import some plasmids we constructed to lysine-deficinent E.coli.
 +
 
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
ii. Week 24-25 ( 2017.08.12-2017.08.25)
  3. Technological applications are matured</p>
+
    <p>&nbsp;</p>
+
<p><span class="label-warning"><font size=4><font color=black> October: </font> </font></span></p>
+
  <span class="lead">&nbsp;&nbsp;
+
<p>  
+
i. Strength:
+
  </span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 1. Convenience.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Adaptability.
+
  <br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; 3. High Cost/Performance Ratio.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  4. Inelastic to change in test conditions.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  ii. Weakness:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Technology Barrier.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  2. Branding Barrier.
+
We detect the growth and fluorescence curve of lysine-deficinent E.coli we had imported our plasmids.
 
<br>
 
<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
 
  3. Strict Market Admittance Criteria.<br>
+
iii. Week 26 (2017.08.26-2017.09.01)
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  4. Distribution Barrier.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iii. Opportunity:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  1. Favorable national economic condition.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  2. Positive national policies.<br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
  3. Uprising Health-consciousness.<br>
+
  <span class="lead">&nbsp;&nbsp;
+
  iv. Threats:</span><br>
+
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
  1. Well-established industries control the high-end markets with related products.
+
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
+
   &nbsp;&nbsp;&nbsp;
  2. Industrial chain is currently complete
+
To achieve the standard of silver medal, we sorted out 19 parts completed in totally.<br>
 +
</p>
 +
 
 +
      <p>&nbsp;</p>
 +
<p><span class="label-warning"><font size=4><font color=black> September: </font> </font></span></p>
 +
  </span><p>&nbsp;&nbsp;<br>
 +
i. Week 27-28 (2017.09.02-2017.09.15)
 
<br>
 
<br>
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
+
   &nbsp;&nbsp;&nbsp;  
  3. Technological applications are matured</p>
+
To reach the gold medal, we worked hard to improve an existing BioBrick, iGEM12_UT_Dallas’s BioBrick(BBa_K876070) and iGEM2006_Imperial’s BioBrick(BBa_J37032)
+
</div>
+
</div>
+
</div>
+
</div>
+
+
  
 +
<br>
 +
ii. Week 29-30 (  2017.09.16-2017.09.29)
 +
<br>
 +
  &nbsp;&nbsp;&nbsp;
 +
To achieve the standard of the copper medal, we have improved the characterizations of BBa_I13973、BBa_I6088、BBa_K584000、BBa_K876070
 +
<br></p>
  
  
<div id="fh5co-started">
+
      <p>&nbsp;</p>
  <div class="overlay"></div>
+
<p><span class="label-warning"><font size=4><font color=black>October: </font> </font></span></p>
<div class="container">
+
  </span><p>&nbsp;&nbsp;<br>
  <div class="row animate-box">
+
i. Week 31-32 (2017.09.30-2017.10.13)
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
+
<br>
<h2>Hire Us!</h2>
+
  &nbsp;&nbsp;&nbsp;
<p>Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.</p>
+
We sorted out our results and steps of the experiment.
<p><a href="#" class="btn btn-default btn-lg">Contact Us</a></p>
+
</div>
+
  </div>
+
</div>
+
</div>
+
  
<footer id="fh5co-footer" role="contentinfo">
+
<br>
<div class="container">
+
ii. Week 33-34 (2017.10.14-2017.10.31)
<div class="row row-pb-md">
+
<br>
<div class="col-md-4 fh5co-widget">
+
  &nbsp;&nbsp;&nbsp;
<h4>Air</h4>
+
We freeze-dried our plasmids and mailed it to IGEM, and then finished our wiki.
<p>Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.</p>
+
<br>
</div>
+
 
<div class="col-md-2 col-md-push-1 fh5co-widget">
+
</p>
<h4>Links</h4>
+
<ul class="fh5co-footer-links">
+
<li><a href="home.html">Home</a></li>
+
<li><a href="#">Team</a></li>
+
<li><a href="Achievement.html">Achievement</a></li>
+
<li><a href="notebook.html">Notebook</a></li>
+
</ul>
+
</div>
+
  
<div class="col-md-2 col-md-push-1 fh5co-widget">
 
<h4>Categories</h4>
 
<ul class="fh5co-footer-links">
 
<li><a href="#">Landing Page</a></li>
 
<li><a href="#">Real Estate</a></li>
 
<li><a href="#">Personal</a></li>
 
<li><a href="#">Business</a></li>
 
<li><a href="#">e-Commerce</a></li>
 
</ul>
 
</div>
 
  
<div class="col-md-4 col-md-push-1 fh5co-widget">
 
<h4>Contact Information</h4>
 
<ul class="fh5co-footer-links">
 
<li>198 West 21th Street, <br> Suite 721 New York NY 10016</li>
 
<li><a href="tel://1234567920">+ 1235 2355 98</a></li>
 
<li><a href="mailto:info@yoursite.com">info@yoursite.com</a></li>
 
<li><a href="http://#">freehtml5.co</a></li>
 
</ul>
 
</div>
 
  
 +
 +
</div>
 
</div>
 
</div>
 +
</div>
 +
</div>
 +
  
<div class="row copyright"> </div>
 
  
</div>
+
 
</footer>
+
<div id="fh5co-started">
 +
    <div class="overlay"></div>
 +
    <div class="container">
 +
      <div class="row animate-box">
 +
        <div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 +
          <h2>Contact Us!</h2>
 +
          <p><center>Please keep reading if you want to contact us.</center></p>
 +
     
 +
        </div>
 +
      </div>
 +
    </div>
 +
  </div>
 +
  <footer id="fh5co-footer" role="contentinfo">
 +
    <div class="container">
 +
      <div class="row row-pb-md">
 +
        <div class="col-md-4 fh5co-widget">
 +
          <h4>BIT</h4>
 +
          <p>It's an excellent Team with thoughtful persons full of funs to the academic</p>
 +
        </div>
 +
        <div class="col-md-2 col-md-push-1 fh5co-widget">
 +
          <h4>Links</h4>
 +
          <ul class="fh5co-footer-links">
 +
            <li><a href="https://2017.igem.org/Team:BIT">Home</a></li>
 +
            <li><a href="https://2017.igem.org/Team:BIT/Team">Team</a></li>
 +
            <li><a href="https://2017.igem.org/Team:BIT/achievement">Achievement</a></li>
 +
            <li><a href="https://2017.igem.org/Team:BIT/Notebook">Notebook</a></li>
 +
          </ul>
 +
        </div>
 +
     
 +
        <div class="col-md-4 col-md-push-1 fh5co-widget">
 +
          <h4>Contact Information</h4>
 +
          <ul class="fh5co-footer-links">
 +
            <li><a href="">Beijing Institute of Technology No.5 Yard,Zhong Guan Cun South Street Haidian District, Beijing, CHINA</li>
 +
            <li><a href="">Wechat:iGEM_BIT</a></li>
 +
            <li><a href="">igem_bit@outlook.com</a></li>
 +
            <li><a href="">Facebook:iGEM_BIT</li>
 +
          </ul>
 +
        </div>
 +
      </div>
 +
      <div class="row copyright"> </div>
 +
    </div>
 +
  </footer>
 
</div>
 
</div>
 
+
<div class="gototop js-top"> <a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a> </div>
<div class="gototop js-top">
+
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
+
</div>
+
 
<!-- JS FILES -->  
 
<!-- JS FILES -->  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  
 
<script src="https://2017.igem.org/Template:BIT/bootstrap/min/Javascript"></script>  
 
<script src="https://2017.igem.org/Template:BIT/bootstrap/min/Javascript"></script>  
 
 
<script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript"></script>  
 
<script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript"></script>  
+
<script src="https://2017.igem.org/Template:BIT/jquery.easing/1/3/Javascript?action=raw&amp;ctype=text/javascript"></script>  
 
+
<!-- Bootstrap -->  
<script src="https://2017.igem.org/Template:BIT/jquery.easing/1/3/Javascript?action=raw&amp;ctype=text/javascript"></script>
+
<script src="https://2017.igem.org/Template:BIT/bootstrap/Javascript?action=raw&amp;ctype=text/javascript"></script>  
<!-- Bootstrap -->
+
<!-- Waypoints -->  
<script src="https://2017.igem.org/Template:BIT/bootstrap/Javascript?action=raw&amp;ctype=text/javascript"></script>
+
<script src="https://2017.igem.org/Template:BIT/jquery/waypoints/min/Javascript?action=raw&amp;ctype=text/javascript"></script>  
<!-- Waypoints -->
+
<!-- Flexslider -->  
<script src="https://2017.igem.org/Template:BIT/jquery/waypoints/min/Javascript?action=raw&amp;ctype=text/javascript"></script>
+
<script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript?action=raw&amp;ctype=text/javascript"></script>  
<!-- Flexslider -->
+
<!-- Main -->  
<script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript?action=raw&amp;ctype=text/javascript"></script>
+
<!-- Main -->
+
 
<script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&amp;ctype=text/javascript"></script>
 
<script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&amp;ctype=text/javascript"></script>
 
+
</body>
</body>
+
 
</html>
 
</html>

Latest revision as of 03:04, 2 November 2017

Journal

 

March:

  
i. Week 1-2 (2017.03.04-2017.03.17)
    After discussion, the main goal of our project was to detect cancer of the liver by using small molecule
ii. Week 3 (2017.03.18-2017.03.24)
    After reviewing the literature, we chose lysine as our small molecule and chose lysine-deficient E.coli as our bacteria.
iii. week 4 (2017.03.25-2017.03.31)
    We chose our main experimental method.

 

April:

  
i. Week 5 (2017.04.01-2017.04.07)
    We listed the plasmids we might use, designed the gene lines, began to construct our part.
ii. Week 6 2017.04.08-2017.04.14)
    We constructed our first part BBa_K2305008.
iii. Week 7 (2017.04.15-2017.04.21)
    We constructed our part BBa_K2305011、BBa_K2305012 and BBa_K2305003、BBa_K2305002.
iv. Week 8 (2017.04.22-2017.04.28)
    We import BBa_K876070 to E.coli, detect the growth and fluorescence curve of E.coil under various lysine concentration.

 

May:

  
i. Week 9 (2017.04.29-2017.05.05)
    We constructed BBa_K2305009、BBa_K2305010.
ii. Week 10 (2017.05.06-2017.05.12)
    We constructed BBa_K2305014、BBa_K2305015、BBa_K2305016.
iii. Week 11 (2017.05.13-2017.05.19)
    We constructed BBa_K2305007、BBa_K2305006.
iv. Week 12 (2017.05.20-2017.05.26)
    We constructed BBa_K2305016、BBa_K2305005.
v. Week 13 (2017.05.27-2017.06.02)
    We constructed BBa_K2305004、BBa_K2305013.

 

June:

  
i. Week 14 (2017.06.03-2017.06.09)
    We begin to detect the growth and fluorescence curve of E.coil which imported our plasmids.
ii. Week 15-17 (2017.06.10-2017.06.30)
    We have achieved the detection of the growth and fluoresence curve of E.coli imported our plasmids.

 

July:

  
i. Week 18 (2017.07.01-2017.07.07)
    We tried to knock out the lysa gene in E.coli by λRed recombination system.
ii. Week 19 ( 2017.07.08-2017.07.14)
    We discussed about the problems we met in the gene-knocked.
iii. Week 20-21 (2017.07.15-2017.07.28)
    We learned how to produce competent cells and produced enough cells..

 

August:

  
i. Week 22-23 (2017.07.29-2017.08.16)
    We import some plasmids we constructed to lysine-deficinent E.coli.
ii. Week 24-25 ( 2017.08.12-2017.08.25)
    We detect the growth and fluorescence curve of lysine-deficinent E.coli we had imported our plasmids.
iii. Week 26 (2017.08.26-2017.09.01)
    To achieve the standard of silver medal, we sorted out 19 parts completed in totally.

 

September:

  
i. Week 27-28 (2017.09.02-2017.09.15)
    To reach the gold medal, we worked hard to improve an existing BioBrick, iGEM12_UT_Dallas’s BioBrick(BBa_K876070) and iGEM2006_Imperial’s BioBrick(BBa_J37032)
ii. Week 29-30 ( 2017.09.16-2017.09.29)
    To achieve the standard of the copper medal, we have improved the characterizations of BBa_I13973、BBa_I6088、BBa_K584000、BBa_K876070

 

October:

  
i. Week 31-32 (2017.09.30-2017.10.13)
    We sorted out our results and steps of the experiment.
ii. Week 33-34 (2017.10.14-2017.10.31)
    We freeze-dried our plasmids and mailed it to IGEM, and then finished our wiki.

Contact Us!

Please keep reading if you want to contact us.